News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
ZELDIS JEROME B
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/21/2023 |
4
| ZELDIS JEROME B (Director) has filed a Form 4 on NEXGEL, INC.|
Txns:
| Granted 15,000 options to buy
@ $2.05, valued at
$30.8k
|
|
| 01/09/2023 |
4
| ZELDIS JEROME B (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 4,000 shares
@ $0
Granted 10,000 options to buy
@ $39.42, valued at
$394.2k
|
|
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2022 |
4
| ZELDIS JEROME B (Executive VP of Research & Dev) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 80,100 options to buy
@ $4.22, valued at
$338k
|
|
| 03/28/2022 |
4
| ZELDIS JEROME B (Director) has filed a Form 4 on NEXGEL, INC.|
Txns:
| Bought 5,300 shares
@ $1.8887, valued at
$10k
|
|
| 01/11/2022 |
4
| ZELDIS JEROME B (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 3,200 shares
@ $0
Granted 12,000 options to buy
@ $38.1, valued at
$457.2k
|
|
| 01/03/2022 |
4
| ZELDIS JEROME B (Director) has filed a Form 4 on NEXGEL, INC.|
Txns:
| Bought 9,091 shares
@ $5.49, valued at
$49.9k
Granted 9,091 options to buy
@ $5.5, valued at
$50k
|
|
| 09/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| ZELDIS JEROME B (Executive VP of Research & Dev) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Bought 5,882 shares
@ $17, valued at
$100k
|
|
| 02/16/2021 |
4
| ZELDIS JEROME B (Executive VP of Research & Dev) has filed a Form 4 on NexImmune, Inc.|
Txns:
| Granted 351,016 options to buy
@ $17, valued at
$6M
|
|
| 01/08/2021 |
4
| ZELDIS JEROME B (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 1,650 shares
@ $0
Granted 10,000 options to buy
@ $66.49, valued at
$664.9k
|
|
| 09/18/2020 |
4
| ZELDIS JEROME B (Director) has filed a Form 4 on SOLIGENIX, INC.|
Txns:
| Granted 15,228 options to buy
@ $1.97, valued at
$30k
|
|
| 07/15/2020 |
4
| ZELDIS JEROME B (Director) has filed a Form 4 on BioSig Technologies, Inc.|
Txns:
| Granted 50,000 options to buy
@ $0 |
|
| 05/28/2020 |
4
| ZELDIS JEROME B (Director) has filed a Form 4 on BioSig Technologies, Inc.|
Txns:
| Bought 1,000 shares
@ $10.4889, valued at
$10.5k
|
|
| 04/16/2020 |
4
| ZELDIS JEROME B (Director) has filed a Form 4 on BioSig Technologies, Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.66, valued at
$233k
|
|
| 01/31/2020 |
4
| ZELDIS JEROME B (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 1,650 shares
@ $0
Granted 10,000 options to buy
@ $51.16, valued at
$511.6k
|
|
| 11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2019 |
4
| ZELDIS JEROME B (Director) has filed a Form 4 on SOLIGENIX, INC.|
Txns:
| Bought 4,000 shares
@ $0.935, valued at
$3.7k
|
|
| 09/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/22/2019 |
4
| ZELDIS JEROME B (Director) has filed a Form 4 on BioSig Technologies, Inc.|
Txns:
| Converted 13,334 shares
@ $3.75, valued at
$50k
Granted 3,804 shares
@ $7.44, valued at
$28.3k
Converted 50 preferred shares
@ $3.75, valued at
$187.5
Exercised 20,000 options to buy
@ $3.4, valued at
$68k
Exercised 1,097 options to buy
@ $6.85, valued at
$7.5k
|
|
| 04/22/2019 |
4
| ZELDIS JEROME B (Director) has filed a Form 4 on SOLIGENIX, INC.|
Txns:
| Bought 10,000 shares
@ $0.7274, valued at
$7.3k
|
|
| 01/24/2019 |
4
| ZELDIS JEROME B (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $33.02, valued at
$462.3k
|
|
| 11/27/2018 |
4
| ZELDIS JEROME B (See Remarks) has filed a Form 4 on Sorrento Therapeutics, Inc.|
Txns:
| Granted 100,000 options
@ $3.57, valued at
$357k
|
|
| 09/28/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2018 |
4
| ZELDIS JEROME B (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $18.01, valued at
$252.1k
|
|
| 11/21/2017 |
4
| ZELDIS JEROME B (Director) has filed a Form 4 on MetaStat, Inc.|
Txns:
| Exercised 50,000 restricted stock units
@ $0 |
|
| 09/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|